MAM
FLGT icon

Marquette Asset Management’s Fulgent Genetics FLGT Stock Holding History

Marquette Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$621K Buy
+30,269
New +$513K 0.08% 38
2025
Q1 		– Sell
-15,777
Closed -$291K – 163
2024
Q4 		$291K Buy
15,777
+5,869
+59% +$115K 0.05% 64
2024
Q3 		$215K Buy
9,908
+1,191
+14% +$26.6K 0.03% 96
2024
Q2 		$171K Buy
+8,717
New +$182K 0.03% 79

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marquette Asset Management's FLGT Position: Q2 2026 in Review

Marquette Asset Management opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 30,269 shares worth $621K. The stake represents 0.08% of the portfolio and ranks #38 among its holdings. This is a return to the name: Marquette Asset Management previously reported a position in FLGT as recently as Q4 2024.

Marquette Asset Management first reported a position in FLGT in Q2 2024 and has held it in 4 quarters since. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Marquette Asset Management held 30,269 shares of Fulgent Genetics worth $621K as of Q2 2026.
  • Fulgent Genetics was a new Marquette Asset Management position in Q2 2026.
  • Fulgent Genetics made up 0.08% of Marquette Asset Management's portfolio in Q2 2026, its #38 holding.
  • Marquette Asset Management first reported a position in Fulgent Genetics in Q2 2024 and has held it in 4 quarters since.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.